Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia
Publication
, Conference
Marx, CE; Keefe, RS; Leimone, LA; Hamer, RM; Bradford, DW; Dunn, L; Payne, VM; Naylor, JC; Savitz, AJ; Strauss, JL; Lieberman, JA; Shampine, LJ
Published in: BIOLOGICAL PSYCHIATRY
April 15, 2007
Duke Scholars
Published In
BIOLOGICAL PSYCHIATRY
ISSN
0006-3223
Publication Date
April 15, 2007
Volume
61
Issue
8
Start / End Page
13S / 13S
Location
San Diego, CA
Publisher
ELSEVIER SCIENCE INC
Conference Name
62nd Annual Scientific Meeting of the Society-of-Biological-Psychiatry
Related Subject Headings
- Psychiatry
- 52 Psychology
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Marx, C. E., Keefe, R. S., Leimone, L. A., Hamer, R. M., Bradford, D. W., Dunn, L., … Shampine, L. J. (2007). Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia. In BIOLOGICAL PSYCHIATRY (Vol. 61, pp. 13S-13S). San Diego, CA: ELSEVIER SCIENCE INC.
Marx, Christine E., Richard S. Keefe, Linda A. Leimone, Robert M. Hamer, Daniel W. Bradford, Lawrence Dunn, Victoria M. Payne, et al. “Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia.” In BIOLOGICAL PSYCHIATRY, 61:13S-13S. ELSEVIER SCIENCE INC, 2007.
Marx CE, Keefe RS, Leimone LA, Hamer RM, Bradford DW, Dunn L, et al. Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia. In: BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC; 2007. p. 13S-13S.
Marx, Christine E., et al. “Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia.” BIOLOGICAL PSYCHIATRY, vol. 61, no. 8, ELSEVIER SCIENCE INC, 2007, pp. 13S-13S.
Marx CE, Keefe RS, Leimone LA, Hamer RM, Bradford DW, Dunn L, Payne VM, Naylor JC, Savitz AJ, Strauss JL, Lieberman JA, Shampine LJ. Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia. BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC; 2007. p. 13S-13S.
Published In
BIOLOGICAL PSYCHIATRY
ISSN
0006-3223
Publication Date
April 15, 2007
Volume
61
Issue
8
Start / End Page
13S / 13S
Location
San Diego, CA
Publisher
ELSEVIER SCIENCE INC
Conference Name
62nd Annual Scientific Meeting of the Society-of-Biological-Psychiatry
Related Subject Headings
- Psychiatry
- 52 Psychology
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences